MyFinsight
Home
Blog
About
Back
Income Statement
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)
source: myfinsight.com
Net income (loss)
attributable to common...
-$71K
(-205.97%↓ Y/Y)
US
$2,224K
Non Us
$300K
Net income (loss)
-$71K
(-155.04%↓ Y/Y)
Biomedical Market
$2,524K
(9.60%↑ Y/Y)
Anti Aging Market
$151K
(4.86%↑ Y/Y)
Total other expense,
net
-$36K
(5.26%↑ Y/Y)
Income (loss) from
operations
-$35K
(-120.96%↓ Y/Y)
Product sales
$2,675K
(9.32%↑ Y/Y)
Interest expense -
related party
$33K
(-8.33%↓ Y/Y)
Other (expense)
income
-$2K
Interest expense
$1K
(-50.00%↓ Y/Y)
Total operating
expenses
$2,710K
(18.86%↑ Y/Y)
Cost of sales
$1,217K
(31.28%↑ Y/Y)
General and
administrative
$1,062K
(17.35%↑ Y/Y)
Selling and marketing
$276K
(-3.50%↓ Y/Y)
Research and development
$155K
(-4.32%↓ Y/Y)
Back